Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/20925957

Download in:

View as

General Info

PMID
20925957